Patents News & Analysis
2 articles
Market Mood
Tesla (TSLA) Revives UK Lawsuit Over 5G Patent License Terms
Tesla (TSLA) successfully revived a lawsuit against U.S. firm InterDigital regarding a 5G patent license ahead of its vehicle launch in the UK. The High Court had ruled in 2024 against Tesla’s bid for a determination of fair, reasonable, and non-discriminatory (FRAND) terms to use certain patents. However, the UK Supreme Court overruled that decision, stating patent owners remain obligated to license under FRAND terms even when part of a patent pool. This ruling could impact patent licensing agreements for Tesla’s upcoming 5G vehicles in Britain and affects the legal landscape for patent use in the automotive sector.
Read More: Tesla (TSLA) Revives UK Lawsuit Over 5G Patent License Terms
US Supreme Court Supports Generic Drugmaker in Patent Case
The US Supreme Court upheld a decision favoring a generic drug manufacturer in a patent dispute involving 'skinny labels.' This ruling allows the sale of generic drugs that reference only certain indications of a patented drug, impacting the pharmaceutical industry. The decision is seen as significant in creating competition among drug manufacturers, potentially lowering prices. The outcome may influence market dynamics for both brand-name and generic drug companies, although specific companies and financial metrics were not disclosed.
Read More: US Supreme Court Supports Generic Drugmaker in Patent Case